ProQR Therapeutics (PRQR) Stock Chart & Stock Price History → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free PRQR Stock Alerts $1.92 -0.02 (-1.03%) (As of 04:00 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ProQR Therapeutics Stock Price Performance5 Day Performance+1.57%1 Month Performance-2.51%3 Month Performance+2.11%6 Month Performance+28.48%Year-To-Date Performance-2.02%1 Year Performance+3.19% Receive PRQR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. PRQR Stock Chart for Monday, May, 20, 2024 PRQR Chart by TradingView ProQR Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.92$1.94+1.04%$2.00$1.9363,742 shs$157.84 million05/16/2024$1.91$1.92+0.52%$1.94$1.8856,461 shs$156.20 million05/15/2024$1.99$1.91-3.78%$1.99$1.88120,723 shs$155.39 million05/14/2024$1.98$1.99+0.25%$2.05$1.9379,896 shs$161.50 million05/13/2024$1.98$1.98$2.00$1.9479,994 shs$161.09 million05/10/2024$2.00$1.98-1.00%$2.16$1.93181,113 shs$161.08 million Get the Latest News and Ratings for PRQR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.00$2.00$2.02$1.9470,248 shs$162.72 million05/08/2024$1.99$2.00+0.50%$2.05$1.96116,202 shs$162.72 million05/07/2024$2.02$1.99-1.49%$2.06$1.9393,710 shs$161.91 million05/06/2024$2.01$2.02+0.50%$2.04$1.9869,106 shs$164.35 million05/03/2024$1.99$2.01+1.01%$2.05$1.97215,686 shs$163.53 million05/02/2024$2.00$1.99-0.50%$2.05$1.9730,250 shs$161.91 million05/01/2024$1.94$2.00+3.09%$2.03$1.85228,506 shs$162.72 million04/30/2024$1.97$1.94-1.52%$2.01$1.9043,198 shs$157.83 million04/29/2024$1.94$1.97+1.55%$2.05$1.93303,816 shs$160.28 million04/26/2024$1.96$1.94-1.02%$1.99$1.9350,793 shs$157.84 million04/25/2024$2.01$1.96-2.49%$2.03$1.84202,007 shs$159.47 million04/24/2024$2.02$2.01-0.50%$2.04$1.9736,411 shs$163.53 million04/23/2024$2.00$2.02+1.00%$2.12$1.99180,845 shs$164.35 million04/22/2024$1.99$2.00+0.50%$2.10$1.97113,072 shs$162.72 million04/19/2024$1.86$1.99+6.99%$2.07$1.87133,009 shs$161.91 million04/18/2024$1.90$1.86-2.11%$2.05$1.81182,612 shs$151.33 million04/17/2024$2.00$1.90-5.00%$2.04$1.86197,897 shs$154.58 million04/16/2024$2.05$2.00-2.20%$2.07$1.91219,851 shs$162.71 million04/15/2024$2.20$2.05-7.05%$2.20$1.91319,416 shs$166.38 million04/12/2024$2.30$2.20-4.35%$2.31$2.11124,895 shs$178.99 million04/11/2024$2.26$2.30+1.77%$2.31$2.2535,668 shs$187.12 million04/10/2024$2.39$2.26-5.44%$2.39$2.25308,139 shs$183.87 million04/09/2024$2.13$2.39+12.21%$2.46$2.15211,141 shs$194.45 million04/08/2024$2.21$2.13-3.62%$2.25$2.13254,828 shs$173.30 million04/05/2024$2.18$2.21+1.38%$2.22$2.1385,430 shs$179.81 million04/04/2024$2.13$2.18+2.59%$2.20$2.12113,429 shs$177.37 million04/03/2024$2.10$2.13+1.19%$2.18$2.0873,293 shs$172.89 million04/02/2024$2.19$2.10-4.11%$2.21$2.05136,788 shs$170.86 million04/01/2024$2.29$2.19-4.36%$2.26$2.10165,619 shs$178.18 million03/29/2024$2.27$2.29+0.88%$2.47$2.23109,180 shs$186.31 million03/28/2024$2.38$2.27-4.62%$2.47$2.23109,109 shs$184.69 million03/27/2024$2.40$2.38-0.83%$2.44$2.3643,391 shs$193.64 million03/26/2024$2.39$2.40+0.42%$2.49$2.3547,369 shs$195.26 million03/25/2024$2.38$2.39+0.42%$2.49$2.37154,773 shs$194.45 millionRead this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash.03/22/2024$2.40$2.38-0.83%$2.42$2.27249,624 shs$193.64 million03/21/2024$2.47$2.40-2.83%$2.52$2.39106,530 shs$195.26 million03/20/2024$2.51$2.47-1.59%$2.59$2.40155,001 shs$200.96 million03/19/2024$2.47$2.51+1.62%$2.64$2.37212,185 shs$204.21 million03/18/2024$2.56$2.47-3.52%$2.57$2.40216,479 shs$200.96 million03/15/2024$2.32$2.56+10.34%$2.70$2.32500,111 shs$206.90 million03/14/2024$2.33$2.32-0.43%$2.48$2.23353,984 shs$187.50 million03/13/2024$2.05$2.33+13.66%$2.46$2.02575,948 shs$188.31 million03/12/2024$2.02$2.05+1.49%$2.12$1.98232,764 shs$165.68 million03/11/2024$2.09$2.02-3.35%$2.16$2.00133,408 shs$163.26 million03/08/2024$1.96$2.09+6.63%$2.12$1.92229,807 shs$168.91 million03/07/2024$1.89$1.96+3.70%$2.00$1.87128,440 shs$158.41 million03/06/2024$1.90$1.89-0.53%$1.92$1.85131,861 shs$152.75 million03/05/2024$1.94$1.90-2.06%$1.96$1.83175,753 shs$153.56 million03/04/2024$1.98$1.94-2.02%$2.00$1.86156,078 shs$156.79 million03/01/2024$2.02$1.98-1.98%$2.05$1.9792,559 shs$160.02 million02/29/2024$2.00$2.02+1.00%$2.12$1.96191,852 shs$163.26 million02/28/2024$2.10$2.00-4.53%$2.12$2.00169,170 shs$161.64 million02/27/2024$2.10$2.10-0.24%$2.18$2.09311,729 shs$169.31 million02/26/2024$2.04$2.10+2.94%$2.13$2.0499,294 shs$169.72 million02/23/2024$2.03$2.04+0.49%$2.08$1.98124,634 shs$164.87 million02/22/2024$1.90$2.03+6.84%$2.05$1.90213,977 shs$164.07 million02/21/2024$1.90$1.90$2.00$1.86241,936 shs$153.56 million02/20/2024$1.95$1.90-2.56%$2.02$1.86257,240 shs$153.56 million02/19/2024$1.95$1.95$2.03$1.90282,000 shs$157.60 million Related Companies: scPharmaceuticals Stock Chart Prelude Therapeutics Stock Chart Capricor Therapeutics Stock Chart Gossamer Bio Stock Chart Rigel Pharmaceuticals Stock Chart Repare Therapeutics Stock Chart CervoMed Stock Chart Alimera Sciences Stock Chart CytomX Therapeutics Stock Chart Skye Bioscience Stock Chart Receive PRQR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProQR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRQR) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProQR Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.